Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Decibel Therapeutics | 2020 | Series D | $82.2M | Cambridge |
| Turning Point Therapeutics | 2020 | Post Ipo Equity | $460.0M | San Diego |
| Aimmune Therapeutics | 2020 | Post Ipo Equity | $200.0M | Brisbane |
| PACT Pharma | 2020 | Series C | $75.0M | Hayward |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 76 | Decibel Therapeutics | Series D | $82.2M | Cambridge, United States |
| 77 | Turning Point Therapeutics | Post Ipo Equity | $460.0M | San Diego, United States |
| 78 | Aimmune Therapeutics | Post Ipo Equity | $200.0M | Brisbane, United States |
| 79 | PACT Pharma | Series C | $75.0M | Hayward, United States |
| 80 | 10X Genomics | Post Ipo Equity | Undisclosed | Pleasanton, United States |
| 81 | Peloton Therapeutics | Series E | $150.0M | Dallas, United States |
Decibel Therapeutics is a hearing company focused on discovering and developing new medicines to protect, repair, and restore hearing.
Turning Point Therapeutics is a pharmaceutical company that discovers and develops precision medicines for cancer and other diseases.
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Pact Pharma is a developer of personalized adoptive T cell therapies designed for the eradication of solid tumors.
10X Genomics ELV solutions and security systems company that provides an innovative genomics platform.
Peloton Therapeutics, a biotech company based in Dallas, is involved in discovering and developing novel drugs for cancer treatments.
Foresite Capital has invested in 81 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Foresite Capital's top investment sectors include Biotechnology, Health Care, Therapeutics, Pharmaceutical, Medical Device. The firm invests across 10 different industry categories.
Among tracked funding rounds, Turning Point Therapeutics received $460.0M in a Post Ipo Equity round. Foresite Capital's total known invested capital is $8.3B.
Foresite Capital's average investment size is $127.9M across its portfolio of 81 companies.
Recent Foresite Capital portfolio additions include Decibel Therapeutics, Turning Point Therapeutics, Aimmune Therapeutics, PACT Pharma. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors